Back to Chris Browne
Chris Browne → JNJ via Tweedy, Browne Co LLC
Chris Browne JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
14
Latest value
$51.2M
Q2 2026
Peak value
$200.2M
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $51.2M | 201.6K | — | — |
| Q1 2026 | $53.7M | 219.5K | — | — |
| Q4 2025 | $48.9M | 236.1K | — | — |
| Q3 2025 | $44.9M | 242.0K | — | — |
| Q2 2025 | $37.4M | 244.7K | — | — |
| Q1 2025 | $72.7M | 438.3K | — | — |
| Q4 2024 | $156.3M | 1.08M | — | — |
| Q3 2024 | $182.5M | 1.13M | — | — |
| Q2 2024 | $165.2M | 1.13M | — | — |
| Q1 2024 | $179.3M | 1.13M | — | — |
| Q4 2023 | $177.9M | 1.14M | — | — |
| Q3 2023 | $177.6M | 1.14M | — | — |
| Q2 2023 | $200.2M | 1.21M | — | — |
| Q1 2023 | $190.9M | 1.23M | — | — |